Spring / 2006

In Every Issue

Editor's Page

Message from the EditorNew statistics are promising, but more is needed.

BY VINAY JAIN, MD

Letters from Our Readers

Letters from Our ReadersFuture of cancer research, advocacy, marijuana debate, survivorship issues, providing hope, and giving thanks. 

Special Report

Drug Company Questions Marketing of Bioidentical HormonesA closer look at bioidentical hormones and why one pharmaceutical company wants the FDA to keep a closer eye on them.

BY NOBLE SPRAYBERRY

Readers' Forum

Lost and FoundFrom mastectomy to reconstruction and beyond.

BY JODI LEAS

Drugs in the News

Kidney, Head and Neck Cancers & MDSRevlimid is approved for certain types of myelodysplastic syndrome, and Sutent was approved for both advanced kidney cancer and gastrointestinal stromal tumor.

BY ELIZABETH WHITTINGTON

Speaking Out

Cancer & Medicare Part DWhat patients need to know about the new prescription drug plan.

BY DIANE BLUM, EXECUTIVE DIRECTOR OF CANCERCARE

Web Exclusives

Mixing Supplements with Cancer TherapyA cautious approach to supplements and a discussion with your physician while taking them during treatment is a must.

BY CHRISTIE L. CARTER

House CallThe new drug for pancreatic cancer and other treatments being tested.

BY HENRY Q. XIONG, MD, PHD

BookshelfReviews of three books covering cancer etiquette, living with colon cancer, and a husband's view on his wife's cancer.

BY KATHY LATOUR

People and PlacesCoretta Scott King died of ovarian cancer, and Sheryl Crow postponed her tour for an operation.

BY ELIZABETH WHITTINGTON

Herceptin in the Spotlight

BY MONICA ZANGWILL, MD

Eight years after its approval, Herceptin emerges as the best weapon against HER2-positive breast cancer.

ARTICLE EXTRAS Pathway to Herceptin Success In the Beginning Web Exclusive: A Dangerous Side Effect Web Exclusive: Q&A with Dr. Dennis Slamon Illustration: Treating HER2-Positive Cancer Chart: The HER Family

Picking Up Momentum for Treating Renal Cell Carcinoma

BY BEVERLY A. CALEY

Advanced treatments take form for a notoriously hard-to-beat cancer.

ARTICLE EXTRAS
Staging Kidney Cancer
Taking a Closer Look
An Unpleasant Surprise
Novel Cytokines for RCC

A New Survivor's Club

BY JENNIFER HAUPT

Unique programs give gratitude and support to co-survivors.

ARTICLE EXTRAS
Supporting Co-Survivors
Co-Survivor Essays

Features

Maneuvering the Maze of Medicare Part D

BY SAM JAFFE

Newer oral cancer drugs will be covered under the new prescription drug plan. 






Diagnosis Cancer

Being Positive?

BY KATHY LATOUR

Dealing with the “tyranny of positive thinking.”

Finding Hope

Closer to Relief

BY ELIZABETH WHITTINGTON

Survivors battle long-term pain with newer methods.

Moving On

A Mission-Driven Life

BY KATHY LATOUR

For some people, cancer becomes a motivator. 

Caregivers' Corner

The Waiting Room

BY CATHERINE K. KAPPHAHN

A father and daughter spend 39 mornings in radiation oncology.